⌘K

Login Start Free

Home/Filings/4/0001169245-21-000104

4//SEC Filing

Mow Jonathan P 4

Accession 0001169245-21-000104

CIK 0001169245other

View on SEC.gov Company Profile

Filed

Nov 2, 8:00 PM ET

Accepted

Nov 3, 7:30 PM ET

Size

6.8 KB

Accession

0001169245-21-000104

Insider Transaction Report

Form 4

Period: 2021-11-03

PhaseBio Pharmaceuticals IncPHAS

DirectorChief Executive Officer

Transactions

Exercise/Conversion
Common Stock
2021-11-03$1.24/sh+20,000$24,800→ 166,850 total
Exercise/Conversion
Employee Stock Option (right to buy)
2021-11-03$1.24/sh−20,000$24,800→ 108,767 total
Exercise: $1.24From: 2018-10-08Exp: 2024-11-04→ Common Stock (20,000 underlying)

Footnotes (1)

[F1]All shares underlying this option have vested.

Documents

1 file

4
wf-form4_163598223753695.xmlPrimary
FORM 4

Issuer

PhaseBio Pharmaceuticals Inc

CIK 0001169245

Entity typeother

Related Parties

1

filerCIK 0001313942

Filing Metadata

Form type: 4
Filed: Nov 2, 8:00 PM ET
Accepted: Nov 3, 7:30 PM ET
Size: 6.8 KB

View on SEC.gov